Anbio Historical Cash Flow
| NNNN Stock | 39.98 11.52 22.37% |
Analysis of Anbio Biotechnology cash flow over time is an excellent tool to project Anbio Biotechnology Class future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 2.3 M or Change In Working Capital of 46.9 K as it is a great indicator of Anbio Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Anbio Biotechnology Class latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anbio Biotechnology Class is a good buy for the upcoming year.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Anbio Biotechnology Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. About Anbio Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Anbio balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Anbio's non-liquid assets can be easily converted into cash.
Anbio Biotechnology Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Anbio Biotechnology Class financial statement analysis. It represents the amount of money remaining after all of Anbio Biotechnology Class operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Anbio Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Anbio Biotechnology Class current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Anbio Biotechnology Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Anbio Biotechnology's Net Income is very stable compared to the past year.
| 2022 | 2023 | 2024 | 2025 (projected) | Free Cash Flow | 4.4M | 898.4K | 2.1M | 2.3M | Change In Cash | 2.9M | 2.6M | 2.1M | 2.4M |
Anbio Biotechnology cash flow statement Correlations
| 0.82 | 0.65 | -0.56 | -0.32 | -0.98 | 0.89 | ||
| 0.82 | 0.28 | -0.04 | 0.18 | -0.87 | 0.81 | ||
| 0.65 | 0.28 | -0.45 | -0.89 | -0.56 | 0.24 | ||
| -0.56 | -0.04 | -0.45 | 0.53 | 0.48 | -0.57 | ||
| -0.32 | 0.18 | -0.89 | 0.53 | 0.19 | 0.06 | ||
| -0.98 | -0.87 | -0.56 | 0.48 | 0.19 | -0.9 | ||
| 0.89 | 0.81 | 0.24 | -0.57 | 0.06 | -0.9 |
Click cells to compare fundamentals
Anbio Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Anbio Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anbio Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anbio Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving together with Anbio Stock
Moving against Anbio Stock
| 0.57 | BCH | Banco De Chile Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Anbio Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anbio Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anbio Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anbio Biotechnology Class to buy it.
The correlation of Anbio Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anbio Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anbio Biotechnology Class moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anbio Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Anbio Biotechnology Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anbio Biotechnology. If investors know Anbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anbio Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.06 | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Anbio Biotechnology Class is measured differently than its book value, which is the value of Anbio that is recorded on the company's balance sheet. Investors also form their own opinion of Anbio Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Anbio Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anbio Biotechnology's market value can be influenced by many factors that don't directly affect Anbio Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anbio Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anbio Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anbio Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.